Cyclophosphamide and mercaptoethane sulfonate therapy for minimal lesion glomerulonephritis [5]

Kidney International

Volumn 56, Issue 6, 1999, Pages 2312-2313

  Kleta, Robert ^a,b  

^a Unikinderklinik   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACROLEIN; CYCLOPHOSPHAMIDE; CYTOSTATIC AGENT; SULFONIC ACID DERIVATIVE;

BLADDER CANCER; DOSE RESPONSE; GLOMERULONEPHRITIS; IDIOPATHIC DISEASE; LETTER; NEPHROTOXICITY; PRIORITY JOURNAL; RISK FACTOR;

EID: 0033435199     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00846.x     Document Type: Letter

References (10)

1. N. Brock J. Stekar J. Pohl C. Niemeyer G. Scheffler Acrolein, the causative factor of urotoxic side-effects of cyclophosphamide, ifosfamide, trofosfamide and sufosfamide Arzneim-Forsch (Drug Res) 29 1979 659 661
2. Who Consultation Essential drugs for cancer chemotherapy Bull World Health Org 72 1994 693 698
3. J.K. Luce J.A. Simons Efficacy of Mesna in preventing further cyclophosphamide-induced hemorrhagic cystitis Med Pediatr Oncol 16 1988 372 374
4. I. Çelik K. Altundag M. Erman E. Baltali Cyclophosphamide-associated carcinoma of the urinary bladder in Behcet's disease Nephron 81 1999 239
5. D. De Ridder H. Van Poppel L. Demonty B. D'hooghe R. Gonsette H. Carton L. Baert Bladder cancer in patients with multiple sclerosis treated with cyclophosphamide J Urol 159 1998 1881 1884
6. M. Kimura Y. Tomita H. Morishita K. Takahashi Presence of mucosal change in the urinary bladder in nonhematuric patients with long-term exposure and/or accumulating high-dose cyclophosphamide—Possible significance of follow-up cystoscopy on preventing development of cyclophosphamide-induced hemorrhagic cystitis Urol Int 61 1998 8 11
7. Y. Samra M. Hertz A. Lindner Urinary bladder tumors following cyclophosphamide therapy: A report of two cases with a review of the literature Med Pediatr Oncol 12 1985 86 91
8. C. Talar-Williams Y.M. Hijazi M.M. Walther W.M. Linehan C.W. Hallahan L. Lubensky C.S. Kerr G.S. Hoffman A.S. Fauci M.C. Sneller Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener granulomatosis Ann Intern Med 124 1996 477 484
9. L.B. Travis R.E. Curtis B. Glimelius E.J. Holowaty F.E. Van Leeuwen C.F. Lynch A. Hagenbeek M. Stovall P.M. Banks J. Adami M.K. Gospodarowicz S. Wacholder P.D. Inskip M.A. Tucker Jd. Boice Jr. Bladder and kidney cancer following cyclophosphamide therapy for non-Hodgkin's lymphoma J Natl Cancer Inst 87 1995 524 530
10. M.P. Goren Oral administration of Mesna with ifosfamide Semin Oncol 23 1996 91 96